Gene · 55
ACP3: acid phosphatase 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ACP3: acid phosphatase 3. Genes, record 55. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/55
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P15309 | Prostatic acid phosphatase | 386 | 17 | Ensembl, GeneID, HGNC |
Source UniProt
Patents117
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 36035 | P15309 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 6047 | P15309 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 165 | P15309 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 237 | P15309 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 5357 | P15309 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 237 | P15309 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 5357 | P15309 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 6047 | P15309 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 1345 | P15309 | Espacenet |
| US 12252547 B2 | 2025-03-18 | 21 | P15309 | Espacenet |
1 to 10 of 117
See all 117 patentsDrugs1
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
| Drug | ChEMBL ID | Mechanism | Action |
|---|---|---|---|
| SIPULEUCEL-T | CHEMBL1237024 | Prostatic acid phosphatase binding agent | BINDING AGENT |
Source ChEMBL
Trials34
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT07219147 | SIPULEUCEL-T | PHASE1 | ClinicalTrials.gov | |
| NCT06134232 | SIPULEUCEL-T | PHASE2 | ClinicalTrials.gov | |
| NCT06100705 | SIPULEUCEL-T | PHASE2 | ClinicalTrials.gov | |
| NCT05806814 | SIPULEUCEL-T | PHASE1 | ClinicalTrials.gov | |
| NCT03686683 | SIPULEUCEL-T | PHASE3 | 2024-10-08 | ClinicalTrials.gov |
| NCT03024216 | SIPULEUCEL-T | PHASE1 | ClinicalTrials.gov | |
| NCT02793765 | SIPULEUCEL-T | PHASE2 | ClinicalTrials.gov | |
| NCT02793219 | SIPULEUCEL-T | PHASE2 | ClinicalTrials.gov | |
| NCT02463799 | SIPULEUCEL-T | PHASE2 | 2021-07-08 | ClinicalTrials.gov |
| NCT02353715 | SIPULEUCEL-T | ClinicalTrials.gov |
1 to 10 of 34
See all 34 trialsNIH grants1,290
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ACP3 papers | Newest fiscal year |
|---|---|---|---|
| ZIABC010666 | Cancer Immunotherapy | 30 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 28 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 24 | 2025 |
| P30CA014520 | UW Comprehensive Cancer Center Support | 23 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 18 | 2025 |
| P50CA097186 | The Pacific Northwest Prostate Cancer SPORE | 12 | 2025 |
| ZIABC010598 | Human Immune Responses to Tumor Antigens for Cancer Immunotherapy | 8 | 2025 |
| P30CA086862 | Cancer Center Support Grant | 7 | 2025 |
| P50CA092629 | SPORE in Prostate Cancer | 7 | 2025 |
| P30CA016042 | Cancer Center Support Grant | 6 | 2025 |
1 to 10 of 1,290Source NIH's project files
See all 1,290 nih grantsPapers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vaccines for Cancer: A Translational Science Review. | JAMA | 2026 | 42766303 | PubTator, text mining | PubMed |
| Tobramycin-Peptide Nucleic Acids Synergize with Polymyxin B and Other Bioactive Compounds to Inhibit Growth of Gram-Negative Bacteria. | ACS Infect Dis | 2026 | 42725966 | PubTator, text mining | PubMed |
| Epidermotropic Metastatic Prostate Adenocarcinoma With Florid Squamous Transformation/Differentiation and Associated Acantholysis. An Unusual Clinicopathologic Entity. | Case Rep Dermatol Med | 2026 | 42699160 | PubTator, text mining | PubMed |
| Eradication of pre-clinical prostate tumors by a lentiviral vector-based immunotherapy. | Mol Ther Oncol | 2026 | 42598525 | PubTator, text mining | PubMed |
| Prostate Cancer Recurrence Mimicking a Primary Paranasal Sinus Tumor on 18F-FDG PET/CT During Treatment for Metastases After 10 Years of Remission. | Case Rep Radiol | 2026 | 42569055 | PubTator, text mining | PubMed |
| Prostatic Acid Phosphatase (PAP) Antibodies to Treat Castration-Resistant Prostate Cancer. | Int J Mol Sci | 2026 | 42511478 | PubTator, text mining | PubMed |
| ACP3-targeted PET imaging agents based on small-molecule ligands for prostate cancer diagnostics and theranostics. | Am J Nucl Med Mol Imaging | 2026 | 42495193 | PubTator, text mining | PubMed |
| Transcriptome analysis of follicular granulosa cells in young women with diminished ovarian reserve. | Reprod Biol Endocrinol | 2026 | 42458461 | PubTator, text mining | PubMed |
| Prostate Cancer: Etiology, Diagnosis, and Treatment. | Serican J Med | 2026 | 42375929 | PubTator, text mining | PubMed |
| Atypical Presentation of Metastatic Prostate Adenocarcinoma in the Presacral Space: A Case Report of Diagnostic Resection via the Kraske Approach. | Am Surg | 2026 | 42360889 | PubTator, text mining | PubMed |
1 to 10 of 3,704
See all 3,704 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/55
GET https://conductscience.org/api/genes/v1/55/patents?page=2